News

Register now for the 20 km of Brussels 2017 for the benefit of the Belgian Charcot Foundation and support scientific research in multiple sclerosis.

For 30 years, the Belgian Charcot Foundation has been raising funds and funding research in multiple sclerosis. On January 19, 2017, teams of Belgian researchers received more than 200,000 euros to fund innovative projects in the fight against this disease.

The knowledge acquired today will form the basis of the drugs of tomorrow, maybe even in many years... from the lab to the patient, how does that happen in practice?

2016 Press Briefing.

True to its mission of public utility in the field of fundamental and translational research, the Charcot Foundation is also setting up the Charcot Fellowship, a doctoral scholarship program for young researchers.

Scientific research requires significant resources and projects often last several years.

The general public has the opportunity to support medical research on multiple sclerosis and to give hope and the perspective of better treatments to the 11,000 Belgians affected by this disease.

By buying our fluorescent markers or our deck of cards at the Comic Book Festival and The Balloon Parade in Brussels.

What do we know about MS today? Why a foundation? What are the prospects for research?

Vitamin D deficiency is frequent in Northern Europe as 90% of Vitamin D is synthesized in the skin under the effect of the sun’s ultraviolet irradiation. Low Vitamin D blood levels in childhood and adolescence are a factor in the development of multiple sclerosis in adulthood. In a Finnish study published in March 2016, mothers with inadequate Vitamin D levels in early pregnancy almost doubled the risk of their children developing multiple sclerosis.

Until now, the fight against smoking has been underestimated in the patients’ population suffering from multiple sclerosis. However, tobacco use clearly aggravates the disease’s prognosis and leads to a more rapid onset of the progressive phase.

The results of basic and clinical multiple sclerosis research over the past ten years are gradually leading to significant changes in its treatment.